Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Hallberg

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|June 25, 2005
Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin IIPer-Ola Johansson, Jimmy Lindberg, Michael J Blackman, et al.
Journal of Medicinal Chemistry|February 5, 2010
Design and synthesis of potent and selective BACE-1 inhibitorsCatarina Björklund, Stefan Oscarson, Kurt Benkestock, et al.
Endocrinology|June 28, 2014
Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndromeSamuel Leblanc, Marie-Claude Battista, Christophe Noll, et al.
Current Opinion in Pharmacology|December 21, 2010
Non-peptide AT2-receptor agonistsU Muscha Steckelings, Mats Larhed, Anders Hallberg, et al.
Journal of Medicinal Chemistry|December 30, 2003
Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activityKarolina Ersmark, Isabella Feierberg, Sinisa Bjelic, et al.
Journal of Medicinal Chemistry|April 19, 2002
Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptorPetra Johannesson, Gunnar Lindeberg, Anja Johansson, et al.
ACS Omega|July 20, 2018
Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Aryl SulfonamidesSudarsana Reddy Vanga, Jonas Sävmarker, Leelee Ng, et al.
Bioorganic & Medicinal Chemistry|October 10, 2008
Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residuesMarcus Bäck, Jonas Nyhlén, Ingemar Kvarnström, et al.
Journal of Medicinal Chemistry|December 8, 2009
HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cellsA K Mahalingam, Linda Axelsson, Jenny K Ekegren, et al.
Bioorganic & Medicinal Chemistry|June 7, 2006
Short pseudopeptides containing turn scaffolds with high AT2 receptor affinityJennie Georgsson, Ulrika Rosenström, Charlotta Wallinder, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|June 25, 2005
Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin IIPer-Ola Johansson, Jimmy Lindberg, Michael J Blackman, et al.
Journal of Medicinal Chemistry|February 5, 2010
Design and synthesis of potent and selective BACE-1 inhibitorsCatarina Björklund, Stefan Oscarson, Kurt Benkestock, et al.
Endocrinology|June 28, 2014
Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndromeSamuel Leblanc, Marie-Claude Battista, Christophe Noll, et al.
Current Opinion in Pharmacology|December 21, 2010
Non-peptide AT2-receptor agonistsU Muscha Steckelings, Mats Larhed, Anders Hallberg, et al.
Journal of Medicinal Chemistry|December 30, 2003
Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activityKarolina Ersmark, Isabella Feierberg, Sinisa Bjelic, et al.
Journal of Medicinal Chemistry|April 19, 2002
Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptorPetra Johannesson, Gunnar Lindeberg, Anja Johansson, et al.
ACS Omega|July 20, 2018
Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Aryl SulfonamidesSudarsana Reddy Vanga, Jonas Sävmarker, Leelee Ng, et al.
Bioorganic & Medicinal Chemistry|October 10, 2008
Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residuesMarcus Bäck, Jonas Nyhlén, Ingemar Kvarnström, et al.
Journal of Medicinal Chemistry|December 8, 2009
HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cellsA K Mahalingam, Linda Axelsson, Jenny K Ekegren, et al.
Bioorganic & Medicinal Chemistry|June 7, 2006
Short pseudopeptides containing turn scaffolds with high AT2 receptor affinityJennie Georgsson, Ulrika Rosenström, Charlotta Wallinder, et al.
Pageof 11